diabetes management

By Dave Muoio 12:26 pm May 20, 2019
On Friday, the FDA issued a warning to patients and providers describing the dangers of diabetes management devices and software that haven’t been assessed by the agency. These include any unapproved or unauthorized continuous glucose monitors, insulin pumps and automated insulin dosing systems, whether used as a standalone device or integrated as part of a glucose management system. “These...
By Jonah Comstock 12:00 pm March 20, 2019
Chronic disease management platform Hello Heart will now integrate with LifeScan OneTouch meters as part of its program for diabetes management. The Redwood City, California-based company started out in hypertension, but has been expanding into diabetes for the past year. OneTouch meters, formerly owned by Johnson & Johnson, are the first of a handful of glucometer brands the company intends...

Credit: Health2Sync

By Dean Koh 12:22 am March 5, 2019
Health2Sync and Novo Nordisk Pharma Ltd. are partnering in Japan to support digital diabetes management and facilitate communication between diabetics and healthcare providers. Last December, the two companies agreed to support the localisation and promotion of the “SyncHealth” App (known as Health2Sync outside of Japan) and web platform for patient management. People living with diabetes require...
By Laura Lovett 02:45 pm February 28, 2019
For folks managing their diabetes with Dexcom, Siri can now answer one more question: What is my glucose level? This morning Dexcom announced a slew of new companion app features for the Dexcom G6 continuous glucose monitoring system, including the ability for Siri to read a user’s glucose level out loud and display graphs directly on the lock screen.  The app, which was released in 2018, will...
By Laura Lovett 04:12 pm January 31, 2019
This morning diabetes self-management company One Drop announced its platform’s integration with Apple’s Health Records. As part of the integration patients who use the One Drop | Experts are able to share their EHRs with their personal diabetes coach. This gives patients the ability to share their vitals, lab results and medication history with One Drop coaches.  This news coincides with the...
By Jonah Comstock 08:05 am January 30, 2019
Chronic condition management startup Livongo has acquired MyStrength, a Denver-based digital behavioral health company. The company did not disclose the acquisition price, but Livongo CEO Glen Tullman told MobiHealthNews the figure is in the tens of millions. “This entry into behavioral was to complete what we call the whole person platform, and to be able to go to someone and say ‘Whatever...
By Dave Muoio 12:26 pm January 3, 2019
Sugar.IQ — the digital diabetes assistant for Guardian Connect system users that is jointly supported by Medtronic and IBM Watson — has a new feature that uses artificial intelligence to predict future low glucose events. Called IQcast, the feature tells users whether they have a low, medium or high chance of dropping below the target blood glucose range within the next one to four hours. These...
By Dave Muoio 03:07 pm December 13, 2018
Onduo, a Verily-Sanofi joint venture focused on digitally-driven diabetes management, is looking to further protect its members from foot ulcers and limb loss. Orpyx Medical Technologies’ diabetic foot ulcer sensors for its members. Thanks to a newly announced deal struck between the companies, Orpyx Medical Technologies’ FDA-cleared SurroSense Rx system will be available to “select members” of...

Photo credit: POPS! Diabetes Care

By Laura Lovett 11:32 am December 10, 2018
Last week, the FDA granted a 510(k) clearance to POPS! Diabetes Care for its latest product, the POPS! one blood glucose monitoring system.  The system is made up of a diabetes coaching app and a small glucose meter that attaches to the back of a user’s smartphone. Users can check their glucose levels on the meter and the results will automatically transfer to the app. Users can track their...
By Dave Muoio 10:33 am November 7, 2018
Editor's note: The headline and body of this article has been edited to clarify that Samsung's integration with the Omnipod Dash have not yet been implemented. Samsung Galaxy smartphones will be serving as the controlling device for Billerica, Massachusetts-based Insulet Corporation’s tubeless insulin pump devices, the two companies announced today. Insulet’s recently FDA-cleared Omnipod Dash...